JCR Pharmaceuticals Co., Ltd.
Symbol: JCRRF
PNK
6.2
USDMarktpreis heute
18.8882
P/E-Verhältnis
-0.0016
PEG-Verhältnis
773.77M
MRK Kapital
- 0.00%
DIV Rendite
JCR Pharmaceuticals Co., Ltd. (JCRRF) Finanzberichte
Bilanz
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 13278 | 30977 | 26260 | |||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | -214 | 244 | -225 | |||||||||||||||||||
balance-sheet.row.net-receivables | 0 | 11137 | 15585 | 8183 | |||||||||||||||||||
balance-sheet.row.inventory | 0 | 18514 | 14636 | 13554 | |||||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 4873 | 990 | 548 | |||||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 47802 | 62188 | 48545 | |||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 32681 | 26782 | 17172 | |||||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 3652 | 2960 | 3232 | |||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 3652 | 2960 | 3232 | |||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 9081 | 1986 | 2797 | |||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 1357 | 2433 | 1739 | |||||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 362 | 783 | 296 | |||||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 47133 | 34944 | 25236 | |||||||||||||||||||
balance-sheet.row.other-assets | 0 | 2 | 2 | 3 | |||||||||||||||||||
balance-sheet.row.total-assets | 0 | 94937 | 97134 | 73784 | |||||||||||||||||||
balance-sheet.row.account-payables | 0 | 1563 | 1324 | 2932 | |||||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 17300 | 15150 | 12850 | |||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 33 | 5915 | 2646 | |||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 5500 | 2950 | 5250 | |||||||||||||||||||
Deferred Revenue Non Current | 0 | -428 | -343 | -378 | |||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 12975 | 13472 | 9687 | |||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 6763 | 3994 | 6203 | |||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 73 | 44 | 42 | |||||||||||||||||||
balance-sheet.row.total-liab | 0 | 42525 | 46048 | 35231 | |||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||||
balance-sheet.row.common-stock | 0 | 9061 | 9061 | 9061 | |||||||||||||||||||
balance-sheet.row.retained-earnings | 0 | 34273 | 33241 | 20904 | |||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 1421 | 1184 | 1159 | |||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 7406 | 7395 | 7255 | |||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 52161 | 50881 | 38379 | |||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 94937 | 97134 | 73784 | |||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 251 | 205 | 174 | |||||||||||||||||||
balance-sheet.row.total-equity | 0 | 52412 | 51086 | 38553 | |||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||||||||||
Total Investments | 0 | 8867 | 2230 | 2572 | |||||||||||||||||||
balance-sheet.row.total-debt | 0 | 22800 | 18100 | 18100 | |||||||||||||||||||
balance-sheet.row.net-debt | 0 | 9522 | -12633 | -8160 |
Kapitalflussrechnung
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 5412 | 19404 | 8653 | |||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 1997 | 1945 | 1892 | |||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | -9221 | -3074 | -983 | |||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 173 | 177 | 149 | |||||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -2956 | -9030 | 323 | |||||||||||||||||||
cash-flows.row.account-receivables | 0 | 3269 | -7501 | -204 | |||||||||||||||||||
cash-flows.row.inventory | 0 | -3877 | -1082 | -4699 | |||||||||||||||||||
cash-flows.row.account-payables | 0 | 238 | -1608 | 2253 | |||||||||||||||||||
cash-flows.row.other-working-capital | 0 | -2586 | 1161 | 2973 | |||||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | -905 | -133 | 307 | |||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -8560 | -11333 | -7527 | |||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | -6717 | 8167 | -2747 | |||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -906 | -300 | -391 | |||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 259 | 300 | 584 | |||||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 922 | -84 | 6791 | |||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -15002 | -3250 | -3290 | |||||||||||||||||||
cash-flows.row.debt-repayment | 0 | -3050 | -750 | -650 | |||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 10 | 10 | 13 | |||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | -10 | -10 | -13 | |||||||||||||||||||
cash-flows.row.dividends-paid | 0 | -2739 | -2169 | -1083 | |||||||||||||||||||
cash-flows.row.other-financing-activites | 0 | 7737 | 740 | 10037 | |||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 1948 | -2179 | 8304 | |||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 1099 | 612 | -22 | |||||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | -17455 | 4473 | 15332 | |||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 13278 | 30733 | 26260 | |||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 30733 | 26260 | 10928 | |||||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | -5500 | 9289 | 10341 | |||||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -8560 | -11333 | -7527 | |||||||||||||||||||
cash-flows.row.free-cash-flow | 0 | -14060 | -2044 | 2814 |
Zeile der Gewinn- und Verlustrechnung
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 34343 | 51082 | 30085 | |||||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 8886 | 10461 | 7812 | |||||||||||||||||||
income-statement-row.row.gross-profit | 0 | 25457 | 40621 | 22273 | |||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.other-expenses | 0 | 58 | 38 | 61 | |||||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 20480 | 20686 | 14003 | |||||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 29366 | 31147 | 21815 | |||||||||||||||||||
income-statement-row.row.interest-income | 0 | 33 | 7 | 7 | |||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 44 | 45 | 42 | |||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 437 | -529 | 384 | |||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 58 | 38 | 61 | |||||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | 437 | -529 | 384 | |||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 44 | 45 | 42 | |||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 1997 | 1945 | 1892 | |||||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.operating-income | 0 | 4975 | 19933 | 8269 | |||||||||||||||||||
income-statement-row.row.income-before-tax | 0 | 5412 | 19404 | 8653 | |||||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 1625 | 4886 | 1764 | |||||||||||||||||||
income-statement-row.row.net-income | 0 | 3772 | 14507 | 6892 |
Häufig gestellte Frage
Wie hoch ist die JCR Pharmaceuticals Co., Ltd. (JCRRF) Gesamtvermögen?
JCR Pharmaceuticals Co., Ltd. (JCRRF) Gesamtvermögen ist 94937000000.000.
Wie hoch ist der Jahresumsatz des Unternehmens?
Der Jahresumsatz ist N/A.
Wie hoch ist die Gewinnspanne des Unternehmens?
Die Gewinnmarge des Unternehmens ist 0.748.
Wie hoch ist der freie Cashflow des Unternehmens?
Der freie Cashflow ist 45.128.
Wie hoch ist die Nettogewinnspanne des Unternehmens?
Die Nettogewinnmarge ist 0.130.
Wie hoch sind die Gesamteinnahmen des Unternehmens?
Der Gesamtertrag ist 0.189.
Was ist der JCR Pharmaceuticals Co., Ltd. (JCRRF) nettogewinn (reingewinn)?
Der Nettogewinn (Nettoeinkommen) ist 3772000000.000.
Wie hoch ist die Gesamtverschuldung des Unternehmens?
Die Gesamtverschuldung ist 22800000000.000.
Wie hoch ist der Betriebsaufwand?
Die Betriebsausgaben sind 20480000000.000.
Wie hoch ist der Bargeldbestand des Unternehmens?
Die Unternehmensliquidität ist 0.000.